With the deep insight into the mechanism of LncRNA, more attentions were paid for its application in cancer detection and therapeutics.[45] Targeting DDR has been innovated cancer therapy.[46,47] In CRC, Lnc5q21.2 increased the sensitivity of ATR inhibitor both in vitro and in vivo. The gene discussed is ATR; the disease is colorectal carcinoma.